Electrophysiological characteristics of supraventricular arrhythmias after cardiac transplantation – a case series by Ivan Prepolec et al.
2021;16(1-2):13.
13. kongres Hrvatskoga kardiološkog društva s međunarodnim sudjelovanjem
Virtualni kongres 10. do 13. 12. 2020. / 21. do 24. 01. 2021. 
Electrophysiological characteristics of supraventricular 
arrhythmias after cardiac transplantation – a case series










University of Zagreb School of 
Medicine, University Hospital 
Centre Zagreb, Zagreb, Croatia
KEYWORDS: supraventricular tachycardia, supraventricular arrhythmia, radiofrequency ablation, car-
diac transplantation.
CITATION: Cardiol Croat. 2021;16(1-2):13. | https://doi.org/10.15836/ccar2021.13
*ADDRESS fOR CORRESPONDENCE: Ivan Prepolec, Klinički bolnički centar Zagreb, Kišpatićeva 12, HR-10000 
Zagreb, Croatia. / Phone: +385-95-8405437 / E-mail: iprepolec@gmail.com
ORCID: Ivan Prepolec, https://orcid.org/0000-0001-5870-202X • Vedran Pašara, https://orcid.org/0000-0002-6587-2315
Borka Pezo-Nikolić, https://orcid.org/0000-0002-0504-5238 • Maja Čikeš, https://orcid.org/0000-0002-4772-5549
Boško Skorić, https://orcid.org/0000-0001-5979-2346 • Davor Puljević, https://orcid.org/0000-0003-3603-2242





Supraventricular tachycardias (SVT) are increasingly recognized late complications after cardiac 
transplantation (CTX). The most commonly described arrhythmias include cavotricuspid isthmus 
(CTI)-dependent atrial flutter (AFL), other macroreentrant atrial tachycardias (MRAT) and focal atrial 
tachycardias (AT). Although surgical substrate can be important, the effect of the surgical technique on 
the mechanism and the occurrence of arrhythmia remains unclear.1-3 We describe characteristics of 
CTX patients who presented with SVT for electrophysiological studies (EPS) at our centre from 2017 to 
2020. Among 6 patients (mean age 48 ± 18 years, 4 of 6 were men), 2 presented during the first year after 
CTX, while 4 patients presented after a long follow-up (13.3 ± 2.8 years). Cardiac rejection was ruled out 
in all patients. In 3 patients significant graft vasculopathy was present. Initially, the conventional EPS 
was performed in all patients. In 5 cases, the initial diagnosis was CTI-dependent AFL and a successful 
radiofrequency ablation of CTI was performed. In one case, the arrhythmia was due to the non-CTI-
dependent MRAT and rate-control strategy was adopted. During the follow-up (29.2 ± 10.2 months), 3 pa-
tients remained without recurrences. In two patients early recurrence was noted (after 1 and 3 months) 
and a second EPS was performed (conventional or electroanatomical mapping) which demonstrated 
the multiple MRAT unsuitable for ablation. These patients were managed conservatively while one of 
them received second CTX due to advanced graft vasculopathy. During the follow-up one patient died 
due to graft rejection. In our group of patients typical AFL and other non-CTI-dependent MRAT were 
observed. In CTI-dependent AFL, conventional radiofrequency ablation was effective, while recurrenc-
es were more difficult to treat. Extensive scarring of the atria is the substrate for multiple MRAT circles 
that are not easily amenable with ablation.
LITERATURE
1. Elsik M, Teh A, Ling LH, Virdee M, Parameshwar J, Fynn SP, Kistler PM. Supraventricular arrhythmias late after orthotopic cardiac transplanta-
tion: electrocardiographic and electrophysiological characterization and radiofrequency ablation. Europace. 2012 Oct;14(10):1498-505. 
https://doi.org/10.1093/europace/eus092
2. Renedo MF, González JL, Giunta GA, Giordanino EF, Ameri AS, Mysuta MA, Ramirez DA, Favaloro LE, Favaloro RR, Absi DO, Galizio NO, Bertolotti 
AM. Radiofrequency ablation of supraventricular arrhythmias after orthotopic heart transplantation: Long-term follow-up of a single-center 
experience. Clin Transplant. 2020 Nov 23:e14165. https://doi.org/10.1111/ctr.14165
3. Mouhoub Y, Laredo M, Varnous S, Leprince P, Waintraub X, Gandjbakhch E, et al. Catheter ablation of organized atrial arrhythmias in orthotopic 
heart transplantation. J Heart Lung Transplant. 2017 Jul 21:S1053-2498(17)31924-1. https://doi.org/10.1016/j.healun.2017.07.022
